In a previous study, we proposed that J2H-1702 can ameliorate liver fibrosis by inhibiting pro-fibrotic gene expression and TGF-β1-mediated collagen synthesis, α-SMA production, and Smad2/3 phosphorylation in a fibrotic environment. The gene discussed is SMAD2; the disease is Hepatic fibrosis.